Reaction Details Report a problem with these data
Target
MAP kinase-interacting serine/threonine-protein kinase 2
Ligand
BDBM30629
Substrate
n/a
Meas. Tech.
Inhibition Assay
pH
7.4±n/a
Temperature
303.15±n/a K
IC50
65±n/a nM
Comments
extracted
Citation
 Heckel, A; Himmelsbach, F; Kley, J; Lehmann-Lintz, T; Redemann, N; Sauer, A; Thomas, L; Wiedenmayer, D; Black, P; Blackaby, W; Linney, I; Austen, M; Danilewicz, J; Schneider, M; Schreiter, K Thienopyrimidines containing a substituted alkyl group for pharmaceutical compositions US Patent  US8853193 Publication Date 10/7/2014 
Target
Name:
MAP kinase-interacting serine/threonine-protein kinase 2
Synonyms:
GPRK7 | MAP kinase signal-integrating kinase 2 | MAP kinase-interacting serine/threonine-protein kinase 2 (MKNK2) | MAP kinase-interacting serine/threonine-protein kinase 2 (MnK2) | MAP-kinase interacting kinase 2 (MNK2) | MKNK2 | MKNK2_HUMAN | MNK2
Type:
Protein
Mol. Mass.:
51870.79
Organism:
Homo sapiens (Human)
Description:
Q9HBH9
Residue:
465
Sequence:
MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA
  
Inhibitor
Name:
BDBM30629
Synonyms:
US8853193, 32-14
Type:
n/a
Emp. Form.:
C22H22FN5O3S
Mol. Mass.:
455.505
SMILES:
Cc1c(sc2ncnc(Nc3ccc(F)cc3OCC3(CC#N)CC3)c12)C(=O)NCCO
Structure:
Search PDB for entries with ligand similarity: